Cooley advised SCYNEXIS on the deal. SCYNEXIS announced its exclusive license agreement with GSK for Brexafemme. The exclusive license agreement gives GSK rights to commercialize SCYNEXIS’ ibrexafungerp...
You must be a Standard 1 Year member to access this content.
Ropes & Gray and Cooley advised 1Life Healthcare Inc., which operates under the name One Medical, on the deal, while Crowell & Moring and Paul, Weiss,...
You must be a Standard 1 Year member to access this content.
Cooley advised SiTime Corporation, while Davis Polk advised the sales agent, Stifel, Nicolaus & Company, in the offering. SiTime Corporation issued an SEC-registered at-the-market offering consisting of...
You must be a Standard 1 Year member to access this content.
Cooley advised Intersect ENT on the deal, while Ropes & Gray advised Medtronic. Intersect ENT, a global ear, nose and throat medical technology leader dedicated to...
You must be a Standard 1 Year member to access this content.
Skadden, Arps, Slate, Meagher & Flom advised Iora Health, while Cooley and Ropes & Gray advised One Medical on the deal. Wilson Sonsini Goodrich & Rosati...
You must be a Standard 1 Year member to access this content.
Cooley LLP advised Instructure on the deal. Instructure, a Thoma Bravo-owned education technology company, announced its agreement to sell Bridge, an employee learning, performance and skills development...
You must be a Standard 1 Year member to access this content.
